A single-blind randomised controlled trial to determine the effectiveness of group Cognitive Behaviour Therapy (CBT) in the prevention of depression in high risk adolescents

ISRCTN ISRCTN19083628
DOI https://doi.org/10.1186/ISRCTN19083628
Secondary identifying numbers HTA 06/37/04
Submission date
28/09/2007
Registration date
01/10/2007
Last edited
08/05/2019
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Background and study aims
We aim of this study is to test whether a school-based depression prevention programme developed in Australia, the Resourceful Adolescent Programme (RAP), is effective at reducing depressive symptoms in high-risk children in the UK.

Who can participate?
Children aged 13-16 from 9-12 mixed comprehensive schools in Bath, Bristol, Nottingham and Swindon

What does the study involve?
Participants complete a questionnaire. Their scores are used to categorise them as either low or high risk of depression or probably depressed. We want to find out what happens to the high risk group (about 20% of each class). Whole classes of children are randomly assigned to receive either the RAP, a placebo (dummy) intervention, or treatment as usual (Personal Health and Social Education - PHSE). For RAP and the placebo intervention each student has a workbook and sessions are led by trained and supervised mental health professionals. We assess children's mood, negative thoughts and self-image before we start and again at 6 and 12 months. This allows us to see whether RAP is effective and if these gains last. We also want to find out whether RAP is good value and so we work out how much it costs and what it saves.

What are the possible benefits and risks of participating?
Not provided at time of registration

Where is the study run from?
Royal United Hospital (UK)

When is the study starting and how long is it expected to run for?
September 2008 to December 2011

Who is funding the study?
NIHR Health Technology Assessment Programme - HTA (UK)

Who is the main contact?
Prof. Paul Stallard
paul.stallard@awp.nhs.uk

Contact information

Prof Paul Stallard
Scientific

Department of Child and Family Psychiatry
Royal United Hospital
Combe Park
Bath
BA1 3NG
United Kingdom

Phone +44 (0)1225 383860
Email paul.stallard@awp.nhs.uk

Study information

Study designCluster randomised controlled trial.
Primary study designInterventional
Secondary study designCluster randomised trial
Study setting(s)School
Study typePrevention
Participant information sheet Not available in web format, please use contact details to request a participant information sheet
Scientific titleA single-blind randomised controlled trial to determine the effectiveness of group Cognitive Behaviour Therapy (CBT) in the prevention of depression in high risk adolescents
Study hypothesisGroup based CBT delivered in schools is effective and cost effective in preventing depression in adolescents at high risk of depression.

More details can be found at: http://www.nets.nihr.ac.uk/projects/hta/063704
Protocol can be found at: http://www.nets.nihr.ac.uk/__data/assets/pdf_file/0006/51378/PRO-06-37-04.pdf
Ethics approval(s)University of Bath Ethical Committee: School for Health: School Research Ethics Approval Panel (SREAP), 18/12/2007
ConditionDepression
InterventionInterventions will be provided during the usual Personal, Social and Health Education (PSHE) sessions (1 hour per session, total of 11 sessions over one school term).

Arm A: Group CBT. CBT recognises the importance of negative thoughts and low self-worth/image in the onset and maintenance of depression. These are therefore actively targeted during CBT with core treatment components including psycho education, identifying and challenging negative/dysfunctional thoughts, identifying personal strengths (thereby enhancing self-esteem/image), managing social problems, and learning to problem solve.

Arm B: Attention placebo. The attention placebo intervention will involve similar time and contact with an external group leader but will not include the active components of the CBT intervention. The content will be based upon the PSHE provided in schools but will be provided by leaders from outside of the school. This will therefore control for the non-specific effects of interventions that are considered important in studies of depression.

Arm C: Usual PSHE
Intervention typeOther
Primary outcome measureChanges in depression symptoms as assessed by the short form Mood and Feelings Questionnaire at 12 months follow-up.
Secondary outcome measures1. Changes in self-image and negative thoughts. These will be assessed at 12 months by the following questionnaires:
1.1. Self Image Profiles (SIP-A). An easily competed 25-item scale for adolescents assesses how they perceive themselves and how they would like to be. Twelve items assess positive attributes (e.g. confident, fun to be with), twelve assess negative attributes (e.g. annoying, moody) and one is neutral (i.e. feel different from others).
1.2. Children's Automatic Thoughts Scale (CATS). This self-completed scale assesses a range of negative self statements in children and young people aged 7-16. For each item the child is asked to rate whether they have had a similar thought over the past week. Each item is rated as "not at all" (scores 0), "sometimes" (scores 1), "fairly often" (scores 2), "often" (scores 3) or "all the time" (scores 4). The 10-item personal failure sub-scale will be used.
2. Cost effectiveness at 12 months
Overall study start date01/09/2008
Overall study end date31/12/2011

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit13 Years
Upper age limit16 Years
SexBoth
Target number of participants5,000 children of whom 1,000 will be at "high risk" of depression.
Total final enrolment5030
Participant inclusion criteriaAll children aged 13-16 attending participating schools (n = 8-12)
Participant exclusion criteriaNo exclusion criteria
Recruitment start date01/09/2008
Recruitment end date31/12/2011

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Royal United Hospital
Bath
BA1 3NG
United Kingdom

Sponsor information

University of Bath (UK)
University/education

School for Health
Bath
BA2 7AY
England
United Kingdom

Website http://www.bath.ac.uk/health/
ROR logo "ROR" https://ror.org/002h8g185

Funders

Funder type

Government

Health Technology Assessment Programme
Government organisation / National government
Alternative name(s)
NIHR Health Technology Assessment Programme, HTA
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 29/11/2010 Yes No
Results article results 01/10/2013 Yes No
Results article cost-effectiveness results 01/12/2014 Yes No
Results article results 05/10/2012 08/05/2019 Yes No

Editorial Notes

08/05/2019: Total final enrolment and publication reference were added.
26/05/2016: Plain English summary added.
29/04/2008: due to a delay in ethics approval, the overall trial start and end dates were updated again. The previous dates were:
Overall trial start date: 01/01/2008.
Overall trial end date: 30/04/2012.
11/01/2008: the overall trial end date was changed from 30/04/2012 to 30/04/2011.